{"id":"NCT00991276","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","briefTitle":"Polysomnography Study Of Pregabalin And Pramipexole Versus Placebo In Patients With Restless Legs Syndrome And Associated Sleep Disturbance","officialTitle":"A Randomized, Double-Blind, Placebo-Controlled, 3-Way Crossover, Multicenter Polysomnography Study Of Pregabalin And Pramipexole In Adults With Restless Legs Syndrome","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-12","primaryCompletion":"2011-06","completion":"2011-06","firstPosted":"2009-10-07","resultsPosted":"2012-10-08","lastUpdate":"2021-02-15"},"enrollment":85,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Restless Legs Syndrome"],"interventions":[{"type":"DRUG","name":"pregabalin","otherNames":["Lyrica"]},{"type":"DRUG","name":"placebo","otherNames":[]},{"type":"DRUG","name":"pramipexole","otherNames":["Mirapex"]}],"arms":[{"label":"pregabalin","type":"EXPERIMENTAL"},{"label":"placebo","type":"PLACEBO_COMPARATOR"},{"label":"pramipexole","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to assess the efficacy and safety of pregabalin and pramipexole versus placebo in the treatment of restless legs syndrome and associated sleep disturbance.","primaryOutcome":{"measure":"Wake After Sleep Onset (WASO)","timeFrame":"Week 5 (End of Intervention Period 1), Week 11 (End of Intervention Period 2) and Week 17 (End of Intervention Period 3) or Early Termination (ET)","effectByArm":[{"arm":"Pregabalin 300 mg","deltaMin":51.5,"sd":null},{"arm":"Pramipexole 0.5 mg","deltaMin":78.42,"sd":null},{"arm":"Placebo","deltaMin":78.6,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.0001"},{"comp":"OG000 vs OG001","p":"<0.0001"},{"comp":"OG001 vs OG002","p":"0.9684"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":9},"locations":{"siteCount":41,"countries":["United States"]},"refs":{"pmids":["24899755"],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A0081185&StudyName=Polysomnography%20Study%20Of%20Pregabalin%20And%20Pramipexole%20Versus%20Placebo%20In%20Patients%20With%20Restless%20Legs%20Syndrome%20And%20Associated%20Sleep%20Disturbance"]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":75},"commonTop":["Somnolence","Dizziness","Headache","Nausea","Dry mouth"]}}